Antiviral Drugs for Seasonal Influenza for 2025-2026

Influenza is generally a self-limited illness, but compli-cations including pneumonia, respiratory failure, and death can occur, especially in persons at increased risk (see Table 1).

Publication Details

Journal
˜The œmedical letter on drugs and therapeutics/˜The œmedical letter
Published
2025-10-09
DOI
https://doi.org/10.58347/tml.2025.1740a
Citations
1
Primary Topic
Influenza Virus Research Studies
Type
article
Field-Weighted Citation Impact
1.35
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Antiviral Drugs for Seasonal Influenza for 2025-2026

1 citations
˜The œmedical letter on drugs and therapeutics/˜The œmedical letter
Influenza Virus Research Studies
1.35
article

Antiviral Drugs for Seasonal Influenza for 2025-2026

article en
1 citations

Abstract

Influenza is generally a self-limited illness, but compli-cations including pneumonia, respiratory failure, and death can occur, especially in persons at increased risk (see Table 1).

˜The œmedical letter on drugs and therapeutics/˜The œmedical letterVol. 67(1740)
Openalex Percentile: Top 15%
Influenza Virus Research Studies
1.35
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Antiviral Drugs for Seasonal Influenza for 2025-2026 · ˜The œmedical letter on drugs and therapeutics/˜The œmedical letter (2025) | TGRS Research Map | TGRS